Evidence map›Paper›PMID 37165164›Full record

ReviewNature reviews. Chemistry2023

Silk chemistry and biomedical material designs.

Jugal Kishore Sahoo, Onur Hasturk, Thomas Falcucci, David L Kaplan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed.

  1. Article
  2. Article
  3. Targeting the circadian negative regulatorMaterials today. Bio · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Engineering Silk Fibroin-Based Biomaterials for Neural Repair.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jugal Kishore SahooDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA. jugal.sahoo@tufts.edu.ORCID http://orcid.org/0000-0003-2503-9115
Onur HasturkDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA.ORCID http://orcid.org/0000-0002-0030-8967
Thomas FalcucciDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA.ORCID http://orcid.org/0000-0002-4598-8839
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, MA, USA. david.kaplan@tufts.edu.ORCID http://orcid.org/0000-0002-9245-7774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silk fibroin has applications in different medical fields such as tissue engineering, regenerative medicine, drug delivery and medical devices. Advances in silk chemistry and biomaterial designs have yielded exciting tools for generating new silk-based materials and technologies. Selective chemistries can enhance or tune the features of silk, such as mechanics, biodegradability, processability and biological interactions, to address challenges in medically relevant materials (hydrogels, films, sponges and fibres). This Review details the design and utility of silk biomaterials for different applications, with particular focus on chemistry. This Review consists of three segments: silk protein fundamentals, silk chemistries and functionalization mechanisms. This is followed by a description of different crosslinking chemistries facilitating network formation, including the formation of composite biomaterials. Utility in the fields of tissue engineering, drug delivery, 3D printing, cell coatings, microfluidics and biosensors are highlighted. Looking to the future, we discuss silk biomaterial design strategies to continue to improve medical outcomes.

Indexed as

FibroinsSilkBiocompatible MaterialsRegenerative MedicineTissue EngineeringBiocompatible MaterialsFibroinsSilk

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.